Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20141209020250N5
IRCT20141209020250N5
Recruiting
Phase 3

Evaluation and comparison of the efficacy and safety of two regimens of diphencyclopropenone (applying different concentrations to identify the effective concentration vs. traditional method) in the treatment of alopecia areata in patients referred to Razi Hospital, 1398-1399.

Tehran University of Medical Sciences0 sites60 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsalopecia areata.Alopecia areata

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
alopecia areata.
Sponsor
Tehran University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patients with alopecia areata
  • •Possibility of regular visit for the patient
  • •Hair loss more then 50 %
  • •The age of the patient greater than 18 years old

Exclusion Criteria

  • •Pregnancy and lactation
  • •Persistent totalis or universalis areata alopecia from infancy
  • •Prominent androgenetic alopecia
  • •No response to diphencyprone test
  • •Patients with hematologic dysplasia
  • •receiving systemic immunosuppressive therapy during recent 3 months

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 3
Crisaborole vesus tacrolimus ointment in the treatment of atopic dermatitisHealth Condition 1: - Health Condition 2: L209- Atopic dermatitis, unspecified
CTRI/2024/05/067660Dr Disha Chakraborty
Not yet recruiting
Not Applicable
A comparison of efficacy and safety of Antihypertensive drugs used in combination and adherence to medication in patients of HypertensioHealth Condition 1: I10- Essential (primary) hypertension
CTRI/2023/09/057435Dr. Madhumita Dixit
Recruiting
Phase 2
Evaluation of the efficacy of Olanzapine and Aripiprazole in patients with psychotic disorders
IRCT20200430047250N1Kermanshah University of Medical Sciences94
Active, not recruiting
Phase 1
A STUDY TO COMPARE HOW SAFE DAPTOMYCIN IS VERSUS OTHER DRUGS IN CHILDREN AGED TWO TO SEVENTEEN WHO HAVE INFECTIONS CAUSED BY THE STAPHYLOCOCCUS AUREUS BACTERIA.Bacteremia caused by Staphylococcus Aureus.MedDRA version: 14.1 Level: LLT Classification code 10054637 Term: Staphylococcal bacteremia System Organ Class: 100000004862Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
EUCTR2012-003447-29-ITCubist Pharmaceuticals, Inc.82
Active, not recruiting
Phase 1
A COMPARATIVE EVALUATION OF THE SAFETY AND EFFICACY OF DAPTOMYCIN VERSUS STANDARD OF CARE IN PEDIATRIC SUBJECTS TWO - SEVENTEEN YEARS OF AGE WITH BACTEREMIA CAUSED BY STAPHYLOCOCCUS AUREUS.Bacteremia caused by Staphylococcus Aureus.MedDRA version: 16.0 Level: LLT Classification code 10054637 Term: Staphylococcal bacteremia System Organ Class: 100000004862Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
EUCTR2012-003447-29-GRCubist Pharmaceuticals, Inc.82